Downregulation of IRF7-mediated type-I interferon response by LmCen–/– parasites is necessary for protective immunity
Leishmaniasis is a tropical disease caused by Leishmania parasites and currently has no licensed vaccines. We developed a dermotropic Leishmania major centrin gene-deleted strain (LmCen<sup>-/-</sup>) as a live attenuated vaccine. Recent studies have shown that type I interferons (IFNs) play important roles in immunity to parasitic and viral pathogens. However, their relevance in protective immunity following vaccination is not understood. We found that immunization with LmCen<sup>-/-</sup> induces a transient increase in type I IFN response along with its regulatory factor IRF7 that is downregulated 7-21 days post-immunization, coincided with the induction of a robust Th1 adaptive immune response. Challenge infection with virulent L. donovani parasites showed a significant reduction of splenic and hepatic parasite burden in IRF7<sup>-/-</sup> mice than wild type mice following immunization with LmCen<sup>-/-</sup>, suggesting that ablation of type I IFN response is a pre-requisite for the induction of LmCen<sup>-/-</sup> mediated Th1 immunity against L. donovani infection.
Authors
- Hira Lal Nakhasi (ORCID: https://orcid.org/0000-0003-4941-1620)
- Telly Sepahpour
- Abhay R. Satoskar (ORCID: https://orcid.org/0000-0001-5989-1520)
- Shinjiro Hamano (ORCID: https://orcid.org/0000-0003-3881-8337)
- Derek D.C. Ireland (ORCID: https://orcid.org/0000-0001-5829-4206)
- Jalal Alshaweesh (ORCID: https://orcid.org/0000-0001-9416-7482)
- Ranadhir Dey (ORCID: https://orcid.org/0000-0003-0069-7867)
- Komudi Singh (ORCID: https://orcid.org/0000-0002-6413-541X)
- Nazli Azodi
- Sreenivas Gannavaram (ORCID: https://orcid.org/0000-0002-6557-8220)
- Risa Nakamura
- Farzaneh Valanezhad
Institutions
- Center for Biologics Evaluation and Research (US)
- United States Food and Drug Administration (US)
- Center for Drug Evaluation and Research (US)
- National Heart, Lung, and Blood Institute (US)
- Nagasaki University (JP)
- The Ohio State University (US)
Publication Details
- Journal
- npj Vaccines
- Published
- 2024-12-19
- DOI
- https://doi.org/10.1038/s41541-024-01032-6
- Citations
- 1
- Primary Topic
- Research on Leishmaniasis Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.54
Funders
- RIKEN